Loading
SKU PP-RES-CJCIPA-10MG
A 1:1 blend of CJC-1295 without DAC (a GHRH receptor agonist) and Ipamorelin (a selective ghrelin receptor agonist), studied together for dual-pathway GH-axis research. Supplied for laboratory and educational research only.
CJC-1295 has been studied for its interaction with the growth hormone-releasing hormone receptor, while Ipamorelin has been examined for selective activity at the ghrelin/GHS receptor. Researchers have investigated the two together for their combined role in growth hormone axis signaling.
Studied in growth hormone secretory pathway research and related endocrine research models.
Summarized from published research literature for informational purposes. Not a recommendation for use, and not an indication that this product is approved or intended for human or veterinary use.
Store lyophilized powder at -20°C, protect from light
Refrigerate at 2-8°C after reconstitution, use within 14 days
Included per batch
Independent HPLC testing
LC-MS, batch matched
Yes. Every batch ships with a lot-specific CoA covering both peptide components.
This product is sold for laboratory and educational research use only. It is not intended for human or veterinary use, and is not a drug, food, or cosmetic under applicable law unless explicitly labeled as such. Statements on this page have not been evaluated by any regulatory authority.
Found this product page helpful? Let us know what you thought of the information, documentation, and details provided here.